Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial

by Flavia Chiuppesi, PhD, John A Zaia, ProfMD, Paul H Frankel, ProfPhD, Rodica Stan, PhD, Jennifer Drake, RN, Brenda Williams, RN, Anne Marie Acosta, LVN, Karyn Francis, RN, Randy A Taplitz, ProfMD, Janet K Dickter, MD, Sanjeet Dadwal, MD, Alfredo G Puing, MD, Deepa D Nanayakkara, MD, Patricia Ash, RN, Yujie Cui, MS, Heidi Contreras, PhD, Corinna La Rosa, PhD, Katrin Tiemann, PhD, Yoonsuh Park, PhD, Joybelle Medina, MS, Angelina Iniguez, MS, Qiao Zhou, MS, Veronica Karpinski, MS, Daisy Johnson, MS, Katelyn Faircloth, MS, Teadora Kaltcheva, PhD, Jenny Nguyen, MS, Mindy Kha, MS, Vu H Nguyen, PhD, Sandra Ortega Francisco, PhD, Alba Grifoni, PhD, Angela Wong, MS, Alessandro Sette, PhD, Felix Wussow, PhD, Don J Diamond, ProfPhD
Published 2022-04-01